Please login to the form below

Not currently logged in
Email:
Password:

Hanover appoints Frances Beves as corp comms lead

She will join the agencynext month from Bell Pottinger

Hanover Frances BevesHanover has appointed Frances Beves as a director in its healthcare team, where she will lead its corporate communications team.

Beves will join the London-based healthcare communications agency next month from Bell Pottinger, which she served as a partner for two years.

Prior to this spent ten years in-house as Lilly's director of European communications, and also held international roles at GSK and GE Healthcare.

She said: “I am very excited to be joining Hanover. The company holds a distinctive position in the pharmaceutical space as it can provide senior counsel and campaigns in brand and corporate comms as well as market access and policy.

“I feel my skillset is well suited to Hanover's offering and I am delighted to be joining the team at a time of strong growth.”

The agency's director of global healthcare Andrew Harrison added: “Hanover's European and UK brand and corporate communications business has expanded over the last 18 months and we are really excited to welcome Frances to build and enhance this part of our business.

“She brings a wealth of knowledge and experience and her time in-house means that she has a depth of understanding of the needs of our clients.”

Hanover, whose recent account wins include Novo Nordisk's public affairs and policy account, has been expanding its healthcare team of late and now employs 20 people who work out of its London and Brussels offices, 

7th July 2015

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....